This inventor holds 1 USPTO granted patent. Top assignee: Wockhardt Limited. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Sheela Chandresekharan Nair: Innovator in Microbial Efflux Pump Inhibition
Introduction
Sheela Chandresekharan Nair is a prominent inventor based in Aurangabad, India. She has made significant contributions to the field of microbiology through her innovative research and development of compounds that inhibit cellular efflux pumps in microbes. Her work is crucial in addressing antibiotic resistance, a growing concern in modern medicine.
Latest Patents
Sheela holds a patent for her invention titled "Inhibitors of Cellular Efflux Pumps of Microbes." This patent describes compounds that act as efflux pump inhibitors, which are essential in combating microbial resistance. The patent also outlines methods for preparing these compounds, their applications, and pharmaceutical compositions that incorporate them. Sheela's patent is a testament to her dedication to advancing medical science and improving treatment options.
Career Highlights
Sheela is currently associated with Wockhardt Limited, a well-known pharmaceutical company. Her role at Wockhardt has allowed her to collaborate with other experts in the field and contribute to the development of innovative healthcare solutions. With her extensive knowledge and experience, she has become a valuable asset to her team and the industry.
Collaborations
Throughout her career, Sheela has worked alongside notable colleagues such as Noel John De Souza and Mahesh Vithalbhai Patel. These collaborations have fostered a productive environment for research and innovation, leading to advancements in their respective fields.
Conclusion
Sheela Chandresekharan Nair's contributions to the field of microbial efflux pump inhibition highlight her role as a leading inventor in the pharmaceutical industry. Her innovative work not only addresses critical health challenges but also paves the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
